Acta Med. 2008, 51: 223-228

Protective Effect of Reversible Cholinesterase Inhibitors (Tacrine, Pyridostigmine) and EqBuChE against VX Poisoning and Brain Acetylcholinesterase Inhibition in Rats

Jiří Bajgar

University of Defence, Faculty of Military Health Sciences, Department of Toxicology, Hradec Králové, Czech Republic

Received October 1, 2008
Accepted December 1, 2008


1. Bajgar J, Fusek J, Kassa J, et al. An attempt to assess functionally minimal acetylcholinesterase activity necessary for survival of rats intoxicated with nerve agents. Chem.-Biol. Interact. 2008; 175:281–5. <>
2. Bajgar J, Fusek J, Skopec F. Changes of cholinesterases in the blood and some tissues following administration of tacrin and its two derivatives to rats. Neurochem. Int. 1994; 24:555–558. <>
3. Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis and treatment. Adv. Clin. Chem. 2004; 38:151–216. <>
4. Bajgar J. The use of chemical weapons and negotiations on their ban: from history to present time (in Czech). 2006; NUCLEUS HK, Hradec Kralove. 180 pp.
5. Bajgar J, Fusek J, Jun D, Kuča K, Bartošová L. Possibility of pharmacological prophylaxis against highly toxic organophosphates. Chem. Listy 2007; 101:81–3.
6. Bajgar J, Hájek P, Karasová J, et al. Inhibition of acetylcholinesterase in different structures of the rat brain following soman intoxication pretreated with Huperzine A. Int. J. Mol. Sci. 2007; 8:1165–76. <>
7. Bajgar J, Hájek P, Slížová D, et al. Changes of acetylcholinesterase activity in different brain areas following intoxication with nerve agents: biochemical and histochemical study. Chem.-Biol. Interact. 2007; 165:14–21. <>
8. Bajgar J, Bartošová L, Kuča K, Jun D, Fusek J. Changes in cholinesterase activities in the rat blood and brain after sarin intoxication pretreated with butyrylcholinesterase. Drug Chem. Toxicol. 2007; 30:351–9. <>
9. Bartošova L, Bajgar J. Characterisation of equine plasma butyrylcholinesterase in vivo and its levels in the blood of laboratory rats (in Czech). Voj. Zdrav. Listy 2007; 76:236–41.
10. Bird SB, Gaspari RJ, Dickson EW. Early death due to severe organophosphate poisoning is a centrally mediated process. Acad. Emerg. Med. 2003; 10:295–8. <>
11. Doctor BP, Raveh L, Wolfe AD, Maxwell DM, Ashani Y. Enzymes as pretreatment drugs for organophosphate toxicity. Neurosci. Behav. Rev. 1991; 15:123–8. <>
12. Doctor BP, Maxwell DM, Saxena A. Preparation and characterization of bioscavengers for possible use against organophosphate toxicity. m-CB Medical Treatment Symposium, 26–30 May 1997, Hradec Kralove. Abstracts p. 17–18.
13. Ellman GL, Courtney DK, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961; 7:88–95. <>
14. Fusek J, Bajgar J, Měrka V. Prophylaxe von Vergiftungen mit Nervenkampfstoffen (Ergebnisse einer klinischen Studie. Koord. Sanitatsdienst 2006; 24: 48–53.
15. Fusek J, Bajgar J, Měrka V. Medikamntose Prophylaxe bei Vergiftungen mit Nervenkampfstoffen. Koord. Sanitatsdienst 2007; 25:41–7.
16. Gordon JJ, Leadbetter L, Maidment MP. The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol. Appl. Pharmacol. 1978; 43:207–16. <>
17. Gordon RK, Haigh JR, Garcia GE, et al. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex in vivo exposure to soman. Chem.-Biol. Interact. 2005; 157:239–46. <>
18. Goswany R, Chaudhuri A, Mahashur AA. Study of respiratory failure in organophosphate and carbamate poisoning. Heart Lung 1994; 23:466–72.
19. Gupta RC. Brain regional heterogeneity and toxicological mechanisms of organophosphates and carbamates. Toxicol. Mech. Meth. 2004; 14:103–43. <>
20. Grauer E, Alkalai D, Kapon J. Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration. Toxicol. Appl. Pharmacol. 2000; 164:301–4. <>
21. Hasan MY, Nurulain, SM, Arafat K, Naseer OP, Petroianu GA. In vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in subchronic low-level exposure. J. Appl. Toxicol. 2004; 24:257–60. <>
22. Kassa J, Karasová J, Musílek K, Kuča K. A comparison of reactivating and therapeutic efficacy of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice. Acta Medica (Hradec Kralove), 2008; in press.
23. Kassa J, Vachek J, Bajgar J, Fusek J. A combination of pyridostigmine with anticholinergic drugs: effective pharmacological pretreatment of soman-poisoned mice. ASA Newslett. 2001; 84:16–19.
24. Kassa J, Vachek J, Bajgar J, Fusek J. A comparison of the effcicacy of pharmacological pretreatments against soman in mice. Voj. Zdrav. Listy 2001; 70 (Suppl):22–5.
25. Katos AM, Conti ML, Moran TS, et al. Abdominal bloating and irritable bowel syndrome like symptoms following microinstillation inhalation exposure to chemical warfare nerve agent VX in guinea pigs. Toxicol. Ind. Hlth 2007; 23:231–40. <>
26. Lallement G, Foquin A, Baubichon D. Heat stress, even extreme, does not induce penetration of pyridostigmine into brain of guinea pigs. Neurotoxicology 1998; 19:759–66.
27. Lallement G, Taille V, Baubichon D, et al. Review of the value of huperzine as pretreatment of organophosphate poisoning. Neurotoxicology 2002; 23:1–5. <>
28. Marino MT, Schuster BG, Brueckner RP, et al. Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humans. J. Clin. Pharmacol. 1998; 38:227–35. <>
29. Marrs TC, Maynard RL, Sidell FR. Chemical Warfare Agents. Toxicology and Treatment. 1996; J. Wiley and Sons, Chicester, New York, Brisbane, Toronto, Singapore.
30. Nambiar MP, Gordon RK, Rezk PE, et al. Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX. Toxicol. Appl. Pharmacol. 2007; 219:142–50. <>
31. Ohbu S, Yamashina A, Takasu N, et al. Sarin poisoning on Tokyo subway. South Med. J. 1997; 90:587–93. <>
32. Patočka J, Bajgar J, Fusek J, Bielavsky J. Protective effect of 1,2,3,4-tetrahydro-9-aminoacridine on acetylcholinesterase inhibition by organophosphorus inhibitors. Coll. Czechoslov. Chem. Commun. 1976; 41:2646–9. <>
33. Patočka J, Jun D, Bajgar J, Kuča K. Prophylaxis against nerve agent intoxication. Def. Sci. J. 2006; 56:775–84. <>
34. Petroianu GA, Hasan MY, Arafat K, Nurulain SM, Schmitt A. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride. J. Appl. Toxicol. 2005; 25:562–7. <>
35. Petroianu GA, Hasan MY, Nurulain SM, et al. Protective agents in acute highdose organophosphate exposure: comparison of rantidine with pralidoxime in rats. J. Appl. Toxicol. 2005; 25:68–73. <>
36. Petroianu GA, Nurulain SM, Arafat K, Rajan S, Hasan MY. Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon. Arch. Toxicol. 2006; 80:777–84. <>
37. Petroianu GA, Hasan MY, Nurulain SM, et al. Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. Pyridostigmine. Toxicol. Appl. Pharmacol. 2007; 219:235–40. <>
38. Radík J. Acetylcholinesterase inhibition in a rat brain with high doses of pyridostigmmine (in Czech). Voj. zdrav. Listy 2002; 71:166–8.
39. Rezk PE, Graham JR, Moran TS, et al. Acute toxic effects of nerve agent VX on respiratory dynamics and functions following microinstillation inhalation exposure in guinea pigs. Inhal. Toxicol. 2007; 19:291–302. <>
40. Rotenberg JS, Newmark J. Nerve attacks on children: diagnosis and management. Pediatrics 2003; 112:648–58. <>
41. Saxena A, Doctor BP, Sun W, et al. HuBChE: A bioscavanger for protection against organophosphate chemical warfare agents. U. S. Army Med. Dep. J. 2004; 7:22–9.
42. Ševelová L, Bajgar J, Saxena A, Doctor BP. Protective effect of equine butyrylcholinesterase in inhalation intoxication of rats with sarin: determination of blood and brain cholinesterase activities. Inhal. Toxicol. 2004; 16:531–6. <>
43. Shih T-M, Kan RK, McDonough JH. In vivo cholinesterase inhibitory specificity of organophosphorus nerve agents. Chem.-Biol. Interact. 2005; 157–158:293–303. <>
44. Sungur M, Guven M. Intensive care management of organophosphate insecticide poisoning. Crit. Care 2001; 5:211–215. <> <PubMed>
45. Wiener SW, Hoffman RS. Nerve agents: a comprehensive review. J. Int. Care Med. 2004; 19:22–37. <>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal